כן פייט ביופרמה Stock: price and insider trades · Israel
כן פייט ביופרמה: what insiders have been doing
כן פייט ביופרמה is a listed company. Its insiders report their share dealings to TASE (ISA). 2 insiders have disclosed 2 filings since 18 October 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
With 2 filings in twelve months, the company is quieter than the median of 14 filings across the 530 companies we follow on the same exchange.
There has been no open-market purchase by an insider of כן פייט ביופרמה for at least a year.
Every figure here comes from the filings published by TASE (ISA) and describes the past, not future prices; it is not investment advice.
Financial data
· cache
- 88 sharesShareXTAETASE:1272:7163:1094473:2026-01-04
- 8 sharesShareXTAETASE:1272:9313:1094473:2026-01-04
2 of 2 declarations
About כן פייט ביופרמה
Kane Biopharma is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on the XTAE market.